CareLit · DOI-Nachweis · Klinische Pädiatrie
Prediction of minimal residual disease in pediatric ALL: Evaluation of the predictive potential of the variables from the ALL-BFM 2000 trial
DOI 10.1055/s-0033-1343620
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Torge, M Zimmermann, A Möricke, R Köhler, A Schrauder, CR Bartram, M Schrappe, M Stanulla
ZeitschriftKlinische Pädiatrie
Ausgabe05/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
In pediatric acute lymphoblastic leukemia (ALL), the most important prognostic factor for the risk of relapse is the evaluation of minimal residual disease (MRD) at defined timepoints. The results of MRD analyses are not available at diagnosis to guide selection of the optimal treatment intensity already early on. In trial ALL BFM 2000, multi-level patient data were collected and are now used to develop neural netwo…
Zitieren
Zitierempfehlung
A Torge, M Zimmermann, A Möricke, R Köhler, A Schrauder, CR Bartram, M Schrappe, M Stanulla (2013) Prediction of minimal residual disease in pediatric ALL: Evaluation of the predictive potential of the variables from the ALL-BFM 2000 trial. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0033-1343620
Mit CareLit weiterarbeiten